PCRX logo

Pacira BioSciences (PCRX) Return On Equity

Annual ROE

5.10%
+2.99%+141.71%

December 31, 2023

Summary

Performance

1-Year Change

+141.71%

3-Year Change

-82.92%

5-Year Change

+3287.5%

15-Year Change

+129.82%

PCRX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.26%
PCRX annual return on equity is higher than 74.26% of companies in Healthcare sector

High & Low

All-time High

138.16%
PCRX annual return on equity is currently -96.31% below its historical high of 138.16%

3-Year Low

2.11%
PCRX annual return on equity is currently +141.71% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PCRX next annual earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Annual Revenue

$674.98 M
PCRX annual revenue is $674.98 million

Annual Net Income

$41.95 M
PCRX annual net profit is $41.95 million

Annual EPS

$0.89
PCRX annual earnings per share is $0.89

Annual ROA

2.58%
PCRX annual return on assets is 2.58%

Quarterly ROE

-10.74%
-18.17%-244.55%

September 30, 2024

Summary

Performance

3-Month Change

-244.55%

1-Year Change

-1320.45%

3-Year Change

-295.27%

5-Year Change

-295.27%

PCRX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.46%
PCRX quarterly return on equity is higher than 64.46% of companies in Healthcare sector

High & Low

All-time High

358.67%
PCRX quarterly return on equity is currently -102.99% below its historical high of 358.67%

3-Year Low

-10.74%
PCRX quarterly return on equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Quarterly Revenue

$168.57 M
PCRX quarterly revenue is $168.57 million

Quarterly Net Income

-$143.47 M
PCRX quarterly net profit is -$143.47 million

Quarterly EPS

-$3.11
PCRX quarterly earnings per share is -$3.11

Quarterly ROA

-5.77%
PCRX quarterly return on assets is -5.77%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

5.10%
PCRX annual return on equity is 5.10%

Annual Net Income

$41.95 M
PCRX annual net profit is $41.95 million

Annual Shareholders Equity

$870.13 M
PCRX annual stockholders equity is $870.13 million

PCRX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+141.7%-1320.5%
3 y3 years-82.9%-295.3%
5 y5 years+3287.5%-295.3%

PCRX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.0%+141.7%-227.1%at low
5 y5-year-82.9%+256.4%-134.3%at low
alltimeall time-96.3%+100.9%-103.0%+98.5%

Pacira BioSciences ROE History

DateAnnualQuarterly
Sep 2024
-
-10.74%(-244.5%)
Jun 2024
-
7.43%(-12.1%)
Mar 2024
-
8.45%(+63.1%)
Dec 2023
5.10%(+141.7%)
5.18%(+488.6%)
Sep 2023
-
0.88%(-249.2%)
Jun 2023
-
-0.59%(-57.2%)
Mar 2023
-
-1.38%(-164.8%)
Dec 2022
2.11%(-66.1%)
2.13%(-24.7%)
Sep 2022
-
2.83%(-48.1%)
Jun 2022
-
5.45%(-0.9%)
Mar 2022
-
5.50%(-10.7%)
Dec 2021
6.22%(-79.2%)
6.16%(-34.8%)
Sep 2021
-
9.45%(-68.2%)
Jun 2021
-
29.70%(+5.2%)
Mar 2021
-
28.22%(-10.0%)
Dec 2020
29.86%(-1016.0%)
31.34%(+1.8%)
Sep 2020
-
30.79%(-1203.6%)
Jun 2020
-
-2.79%(>+9900.0%)
Mar 2020
-
-0.02%(-99.4%)
Dec 2019
-3.26%(+1937.5%)
-3.26%(-593.9%)
Sep 2019
-
0.66%(-72.5%)
Jun 2019
-
2.40%(-2.0%)
Mar 2019
-
2.45%(-1631.3%)
Dec 2018
-0.16%(-99.1%)
-0.16%(-89.1%)
Sep 2018
-
-1.47%(-63.6%)
Jun 2018
-
-4.04%(-67.3%)
Mar 2018
-
-12.34%(-25.0%)
Dec 2017
-17.10%
-16.45%(-21.0%)
Sep 2017
-
-20.81%(-24.5%)
Jun 2017
-
-27.55%(+18.3%)
DateAnnualQuarterly
Mar 2017
-
-23.29%(+35.8%)
Dec 2016
-17.35%(-1926.3%)
-17.15%(+3.1%)
Sep 2016
-
-16.64%(+219.4%)
Jun 2016
-
-5.21%(+229.7%)
Mar 2016
-
-1.58%(-266.3%)
Dec 2015
0.95%(-107.4%)
0.95%(-82.9%)
Sep 2015
-
5.55%(+133.2%)
Jun 2015
-
2.38%(-435.2%)
Mar 2015
-
-0.71%(-94.3%)
Dec 2014
-12.92%(-89.2%)
-12.44%(-66.1%)
Sep 2014
-
-36.67%(-43.5%)
Jun 2014
-
-64.91%(-36.6%)
Mar 2014
-
-102.44%(-8.6%)
Dec 2013
-119.34%(+30.3%)
-112.06%(+6.4%)
Sep 2013
-
-105.29%(+12.4%)
Jun 2013
-
-93.66%(+2.6%)
Mar 2013
-
-91.31%(+14.0%)
Dec 2012
-91.62%(+2.1%)
-80.11%(-14.2%)
Sep 2012
-
-93.35%(-10.0%)
Jun 2012
-
-103.73%(-29.9%)
Mar 2012
-
-148.07%(-53.6%)
Dec 2011
-89.76%(-260.0%)
-319.34%(-55.5%)
Sep 2011
-
-717.11%(-299.9%)
Jun 2011
-
358.67%(+168.7%)
Mar 2011
-
133.46%(+105.9%)
Dec 2010
56.11%(-59.4%)
64.82%(-25.5%)
Sep 2010
-
87.04%(-10.4%)
Jun 2010
-
97.12%(+6.4%)
Mar 2010
-
91.31%(+34.6%)
Dec 2009
138.16%(-124.7%)
67.82%
Dec 2008
-558.91%
-

FAQ

  • What is Pacira BioSciences annual return on equity?
  • What is the all time high annual ROE for Pacira BioSciences?
  • What is Pacira BioSciences annual ROE year-on-year change?
  • What is Pacira BioSciences quarterly return on equity?
  • What is the all time high quarterly ROE for Pacira BioSciences?
  • What is Pacira BioSciences quarterly ROE year-on-year change?

What is Pacira BioSciences annual return on equity?

The current annual ROE of PCRX is 5.10%

What is the all time high annual ROE for Pacira BioSciences?

Pacira BioSciences all-time high annual return on equity is 138.16%

What is Pacira BioSciences annual ROE year-on-year change?

Over the past year, PCRX annual return on equity has changed by +2.99% (+141.71%)

What is Pacira BioSciences quarterly return on equity?

The current quarterly ROE of PCRX is -10.74%

What is the all time high quarterly ROE for Pacira BioSciences?

Pacira BioSciences all-time high quarterly return on equity is 358.67%

What is Pacira BioSciences quarterly ROE year-on-year change?

Over the past year, PCRX quarterly return on equity has changed by -11.62% (-1320.45%)